Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Drug Development and Industrial Pharmacy

• Publication date

  2012-01-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/03639045.2011.587433PMID 21671838
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release.

  2009cited by this paper
• Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets.

  2009cited by this paper
• Sustained-release pharmaceutical formulations

  2009cited by this paper
• Multiparticulate formulation approach to pulsatile drug delivery: current perspectives.

  2009cited by this paper
• Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.

  2009cited by this paper
• Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.

  2009cited by this paper
• Physical blends of starch graft copolymers as matrices for colon targeting drug delivery systems

  2009cited by this paper
• Prediction of drug release from ethylcellulose coated pellets.

  2009cited by this paper
• A novel preparation method for PLGA microspheres using non-halogenated solvents.

  2008cited by this paper
• Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.

  2008cited by this paper
• Microspheres for colonic delivery of ketoprofen-hydroxypropyl-beta-cyclodextrin complex.

  2008cited by this paper
• Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.

  2008cited by this paper
• Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.

  2008cited by this paper
• Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.

  2008cited by this paper
• Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.

  2008cited by this paper
• Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.

  2008cited by this paper
• Production of instant soymilk powders by ultrafiltration, spray drying and fluidized bed agglomeration

  2008cited by this paper
• Surface modification of silica particles by dry coating: Characterization and powder ageing

  2007cited by this paper
• Advanced drug formulation design to optimize therapeutic outcomes

  2007cited by this paper
• Advanced Drug Formulation Design to Optimize Therapeutic Outcomes

  2007cited by this paper
• Controlled release of ketoprofen from electrospun poly(vinyl alcohol) nanofibers

  2007cited by this paper
• In vitro controlled drug release from loaded microspheres--dose regulation through formulation.

  2007cited by this paper
• Formas farmacêuticas sólidas orais de liberação prolongada: sistemas monolíticos e multiparticulados

  2007cited by this paper
• Preparation and evaluation of waxes/fat microspheres loaded with lithium carbonate for controlled release

  2007cited by this paper
• Trabalho realizado na gerência de Medicamentos Novos, Pesquisa e Ensaios Clínicos, da Agência Nacional de Vigilância Sanitária- Anvisa,

  2006cited by this paper
• Avaliação in vitro de medicamentos de liberação prolongada: aplicação de métodos estatísticos, modelos dependentes e independentes de análise

  2005cited by this paper
• In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads

  2005cited by this paper
• A new approach for preparing a controlled release ketoprofen tablets by using beeswax.

  2005cited by this paper
• Compaction of enteric-coated pellets: influence of formulation and process parameters on tablet properties and in vivo evaluation.

  2004cited by this paper
• Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay

  2004cited by this paper
• Agência Nacional de Vigilância Sanitária

  2004cited by this paper
• Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen

  2004cited by this paper
• Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.

  2003cited by this paper
• Bioavailability of a new ketoprofen formulation for once-daily oral administration.

  2002cited by this paper
• Modeling and comparison of dissolution profiles.

  2001cited by this paper
• An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.

  2001cited by this paper
• Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC).

  2001cited by this paper
• Formas farmacêuticas monolíticas como sistemas multiparticulados

  2001cited by this paper
• Effects of ultrasound-assisted compaction on Ketoprofen/Eudragit S100 mixtures.

  1999cited by this paper
• Fluidized-bed spray coated porous hydrogel beads for sustained release of diclofenac sodium

  1997cited by this paper
• Matrix pellets based on the combination of waxes, starches and maltodextrins

  1996cited by this paper
• Formulation of prolonged release lipid micropellets by emulsion congealing: Optimization of ketoprofen entrapment and release

  1995influential reference
• Martindale : the extra pharmacopoeia

  1993cited by this paper
• Processing factors affecting particle size and in vitro drug release of sustained-release ibuprofen microspheres

  1993influential reference
• Modelling of drug release from pellets coated with an insoluble polymeric membrane

  1991cited by this paper
• Development and Evaluation of Sustained-Release Ibuprofen-Wax Microspheres. I. Effect of Formulation Variables on Physical Characteristics

  1991cited by this paper
• Clinical Pharmacokinetics of Ketoprofen and Its Enantiomers

  1990cited by this paper
• Ketoprofen: The European Experience

  1988cited by this paper
• Ibuprofen microcapsules from stearic acid. Part 1: Effect of particle size.

  1985cited by this paper
• Analysis of Fickian and non-Fickian drug release from polymers.

  1985cited by this paper
• The evaluation of antacid value of magnesium-aluminium trisilicate dihydrate tablets.

  1985cited by this paper
• Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.

  1984cited by this paper
• A comparative trial of a controlled-release formulation of ketoprofen ('Oruvail') and a conventional capsule formulation of ketoprofen ('Orudis') in patients with osteoarthritis of the hip.

  1984cited by this paper
• Mechanisms of solute release from porous hydrophilic polymers

  1983cited by this paper
• Bioavailability Study on a New Slow-Release Formulation of Ketoprofen

  1982cited by this paper
• Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets

  1978cited by this paper
• Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin.

  1976cited by this paper
• Ketoprofen. A survey of current publications.

  1976cited by this paper
• Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data.

  1976cited by this paper
• Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.

  1973cited by this paper
• Analytical profiles of drug substances

  1972cited by this paper
• Surgery for rheumatoid arthritis.

  1968cited by this paper
• Drug release from wax matrices. I. Analysis of data with first-order kinetics and with the diffusion-controlled model.

  1968cited by this paper
• Some wax formulations of sulfaethylthiadiazole produced by aqueous dispersion for prolonged-release medication.

  1966cited by this paper
• MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

  1963cited by this paper
• THE UNITED STATES PHARMACOPEIAL CONVENTION

  1930cited by this paper

• Development, optimization and in vitro-in vivo evaluation of solid lipid microparticles for improved pharmacokinetic profile of bisoprolol

  2023cites this paper
• Solid phase wax coating of N-acetylcysteine (NAC) to decrease its solubility profile as a ready to mix supplement

  2022cites this paper
• Chemistry, Biological Activities, and Uses of Carnauba Wax

  2021cites this paper
• Formulation, characterization, and pharmacokinetic evaluation of Ivabradine-Nebivolol co-encapsulated lipospheres

  2021cites this paper
• Antiinflammatory activity of carnauba wax microparticles containing curcumin

  2020cites this paper
• Formulation, characterization and statistical optimization of enalapril-loaded lipospheres

  2020cites this paper
• Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy

  2019cites this paper
• Textural, Color, Hygroscopic, Lipid Oxidation, and Sensory Properties of Cookies Containing Free and Microencapsulated Chia Oil

  2018cites this paper
• Evaluation of retrograded starch as excipient for controlled release matrix tablets

  2017cites this paper
• Sustained release biodegradable solid lipid microparticles: Formulation, evaluation and statistical optimization by response surface methodology

  2017cites this paper
• Floating ability and drug release evaluation of gastroretentive microparticles system containing metronidazole obtained by spray drying

  2017cites this paper
• Formulation studies on ibuprofen sodium–cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen

  2016cites this paper
• A novel approach in mucoadhesive drug delivery system to improve zidovudine intestinal permeability

  2016cites this paper
• Cellulose triacetate films obtained from sugarcane bagasse: Evaluation as coating and mucoadhesive material for drug delivery systems.

  2016cites this paper
• In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system

  2015cites this paper
• Low Density Lipid Nanoparticles for Solid Tumor Targeting

  2014cites this paper
• Natural polymer‐stabilized multiple water‐in‐oil‐in‐water emulsions: a novel dermal drug delivery system for 5‐fluorouracil

  2014cites this paper
• A novel automated alternating current biosusceptometry method to characterization of controlled-release magnetic floating tablets of metronidazole

  2014cites this paper
• Films from resistant starch-pectin dispersions intended for colonic drug delivery.

  2014cites this paper
• MATRIX DRUG DELIVERY SYSTEM: A CONCISE REVIEW

  2012cites this paper
• Development and validation of a HPLC method for the determination of trans-resveratrol in spiked human plasma

  2012cites this paper
• Synthesis and Cytotoxicity Evaluation of 13-n-Alkyl Berberine and Palmatine Analogues as Anticancer Agents

  2012cites this paper
• In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride

  2012cites this paper